Asia Pacific Organoids Market Forecast to 2030

Asia Pacific Organoids Market Forecast to 2030 – Regional Analysis – by Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), and Type (Instruments, Consumables, and Services)

Send Enquiry
Item ID: TIPRE00018852 Category: Tags: , ,

$2,100$3,500

Description

The Asia Pacific organoids market is expected to grow from US$ 341.24 million in 2022 to US$ 1,866.32 million by 2030. It is estimated to grow at a CAGR of 23.7% from 2022 to 2030.

Focus on Drug Discovery Activities Fuel the Asia Pacific Organoids Market

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ’s original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study ‘CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,’ published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids’ safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.

Asia Pacific Organoids Market Overview

The Asia Pacific organoids market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as increasing incidences of cancer, growing demand for gene mutation and cancer research, government efforts to raise awareness related to human organoids, supportive regulations for the development and commercialization of advanced human organoids products, and increased funding for organoids research.

Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Organoids Market Segmentation

The Asia Pacific organoids market is segmented into organ type, type application, source, and country.

Based on organ type, the Asia Pacific organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Asia Pacific organoids market in 2022.

Based on type, the Asia Pacific organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Asia Pacific organoids market in 2022.

Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Asia Pacific organoids market in 2022.

Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Asia Pacific organoids market in 2022.

Based on country, the Asia Pacific organoids market is segmented into the Japan, China, Australia, India, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific organoids market in 2022.

Cellesce, Corning Inc, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific organoids market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 23.7% CAGR, the Asia Pacific Organoids Market is speculated to be worth US$ 1,866.32 million by 2030, saysthe research team

According tothe research team’ research, the Asia Pacific Organoids market was valued at US$ 341.24 million in 2022 and is expected to reach US$ 1,866.32 million by 2030, registering a CAGR of 23.7% from 2022 to 2030. Growing adoption of personalized drugs and rising focus on developing alternatives for animal testing models are the critical factors attributed to the Asia Pacific Organoids market expansion.

Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to a study published by Personalized Medicine Coalition (PMC), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. Recent research has highlighted that more than 50% of consumers are interested in purchasing customized products or services. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.

Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor’s genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene–drug association treatment, identification of new therapies, and prediction of patient outcomes.

Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

On the contrary, issues related to incorporation of organoids into existing workflows hampers the Asia Pacific organoids market.

Based on organ type, the Asia Pacific organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held 23.1% share of Asia Pacific organoids market in 2022, amassing US$ 78.97 million. It is projected to garner US$ 424.02 million by 2030 to expand at 23.4% CAGR during 2022–2030.

Based on type, the Asia Pacific organoids market is segmented into instruments, consumables, and services. The consumables segment held 57.5% share of Asia Pacific organoids market in 2022, amassing US$ 196.05 million. It is projected to garner US$ 1,136.42 million by 2030 to expand at 24.6% CAGR during 2022–2030.

Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held 29.6% share of Asia Pacific organoids market in 2022, amassing US$ 100.84 million. It is projected to garner US$ 577.32 million by 2030 to expand at 24.4% CAGR during 2022–2030.

Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held 72.2% share of Asia Pacific organoids market in 2022, amassing US$ 246.54 million. It is projected to garner US$ 1,391.07 million by 2030 to expand at 24.1% CAGR during 2022–2030.

Based on country, the Asia Pacific organoids market has been categorized into the Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that Japan captured 36.0% share of Asia Pacific organoids market in 2022. It was assessed at US$ 122.86 million in 2022 and is likely to hit US$ 643.99 million by 2030, exhibiting a CAGR of 23.0% during 2022–2030.

Key players operating in the Asia Pacific organoids market are Cellesce, Corning Inc, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc, among others.

In Aug 2021, InSphero AG announced that it is making its proprietary, patented 96- and 384-microwell plates available to researchers, enabling them to access the same plate technology used in the company’s flagship, assay-ready 3D InSight Human Liver Microtissues. The plates, engineered specifically for 3D cultures of spheroids and organoids, are available via InSphero’s online R&D Solutions Store.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Edge Computing Market – By Component
1.3.2 Edge Computing Market – By Enterprise Size
1.3.3 Edge Computing Market – By Application
1.3.4 Edge Computing Market – By Verticals
1.3.5 Edge Computing Market- By Region
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Edge Computing Market Landscape
4.1 Market Overview
4.2 Ecosystem Analysis
4.3 Europe Expert Opinion
5. Europe Edge Computing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Adoption of IoT across Industries
5.1.2 Extremely Low Latency and High Availability of Bandwidth
5.2 Market Restraints
5.2.1 Rising Risks and Concerns Related to Data Privacy
5.2.2 Challenges Associated with Remote Management
5.3 Market Opportunities
5.3.1 Introduction of Autonomous Vehicles and Connected Car Infrastructure
5.4 Market Trends
5.4.1 Emergence of 5G Network to Deliver Instant Communication Experiences
5.5 Impact Analysis of Drivers and Restraints
6. Edge Computing Market – Europe Analysis
6.1 Europe Edge Computing Market Overview
6.2 Europe Edge Computing Market – Revenue and Forecast to 2028 (US$ Billion)
7. Europe Edge Computing Market Analysis – By Component
7.1 Overview
7.2 Europe Edge Computing Market, By Component (2021 And 2028)
7.3 Hardware
7.3.1 Overview
7.3.2 Hardware: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
7.4 Software
7.4.1 Overview
7.4.2 Software: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
7.5 Services
7.5.1 Overview
7.5.2 Services: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
8. Europe Edge Computing Market Analysis – By Application
8.1 Overview
8.2 Europe Edge Computing Market, By Application (2021 And 2028)
8.3 Smart Cities
8.3.1 Overview
8.3.2 Smart Cities: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
8.4 Industrial Internet of Things (IIoT)
8.4.1 Overview
8.4.2 Industrial Internet of Things (IIoT): Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
8.5 Remote Monitoring
8.5.1 Overview
8.5.2 Remote Monitoring: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
8.6 Content Delivery
8.6.1 Overview
8.6.2 Content Delivery: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
8.7 Augmented Reality and Virtual Reality
8.7.1 Overview
8.7.2 Augmented Reality and Virtual Reality: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
9. Europe Edge Computing Market Analysis – By Enterprise Size
9.1 Overview
9.2 Europe Edge Computing Market, By Enterprise Size (2021 and 2028)
9.3 Small and Medium Enterprises
9.3.1 Overview
9.3.2 Small and Medium Enterprises: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
9.4 Large Enterprises
9.4.1 Overview
9.4.2 Large Enterprises: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10. Europe Edge Computing Market Analysis – By Industry
10.1 Overview
10.2 Europe Edge Computing Market, By Industry (2021 And 2028)
10.3 Manufacturing
10.3.1 Overview
10.3.2 Manufacturing: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.4 Energy & Utility
10.4.1 Overview
10.4.2 Energy & Utility: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.5 Government
10.5.1 Overview
10.5.2 Government: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.6 IT and Telecom
10.6.1 Overview
10.6.2 IT and Telecom: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.7 Healthcare
10.7.1 Overview
10.7.2 Healthcare: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.8 Retail and Consumer Goods
10.8.1 Overview
10.8.2 Retail and Consumer Goods: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.9 Transportation and Logistics
10.9.1 Overview
10.9.2 Transportation and Logistics: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
10.10 Others
10.10.1 Overview
10.10.2 Others: Europe Edge Computing Market Revenue and Forecast To 2028 (US$ Billion)
11. Europe Edge Computing Market -Country Analysis
11.1 Europe: Edge Computing Market
11.1.1 Overview
11.1.2 Europe Edge Computing Market Breakdown, by Country
11.1.2.1 Germany Edge Computing Market, Revenue and Forecast to 2028
11.1.2.1.1 Germany Edge Computing Market Breakdown, by Component
11.1.2.1.2 Germany Edge Computing Market Breakdown, by Application
11.1.2.1.3 Germany Edge Computing Market Breakdown, by Enterprise Size
11.1.2.1.4 Germany Edge Computing Market Breakdown, by Industry
11.1.2.2 France Edge Computing Market, Revenue and Forecast to 2028
11.1.2.2.1 France Edge Computing Market Breakdown, by Component
11.1.2.2.2 France Edge Computing Market Breakdown, by Application
11.1.2.2.3 France Edge Computing Market Breakdown, by Enterprise Size
11.1.2.2.4 France Edge Computing Market Breakdown, by Industry
11.1.2.3 Italy Edge Computing Market, Revenue and Forecast to 2028
11.1.2.3.1 Italy Edge Computing Market Breakdown, by Component
11.1.2.3.2 Italy Edge Computing Market Breakdown, by Application
11.1.2.3.3 Italy Edge Computing Market Breakdown, by Enterprise Size
11.1.2.3.4 Italy Edge Computing Market Breakdown, by Industry
11.1.2.4 UK Edge Computing Market, Revenue and Forecast to 2028
11.1.2.4.1 UK Edge Computing Market Breakdown, by Component
11.1.2.4.2 UK Edge Computing Market Breakdown, by Application
11.1.2.4.3 UK Edge Computing Market Breakdown, by Enterprise Size
11.1.2.4.4 UK Edge Computing Market Breakdown, by Industry
11.1.2.5 Russia Edge Computing Market, Revenue and Forecast to 2028
11.1.2.5.1 Russia Edge Computing Market Breakdown, by Component
11.1.2.5.2 Russia Edge Computing Market Breakdown, by Application
11.1.2.5.3 Russia Edge Computing Market Breakdown, by Enterprise Size
11.1.2.5.4 Russia Edge Computing Market Breakdown, by Industry
11.1.2.6 Rest of Europe Edge Computing Market, Revenue and Forecast to 2028
11.1.2.6.1 Rest of Europe Edge Computing Market Breakdown, by Component
11.1.2.6.2 Rest of Europe Edge Computing Market Breakdown, by Application
11.1.2.6.3 Rest of Europe Edge Computing Market Breakdown, by Enterprise Size
11.1.2.6.4 Rest of Europe Edge Computing Market Breakdown, by Industry
12. Europe Edge Computing Market-Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Merger and Acquisition
12.4 New Product Launch
13. Company Profiles
13.1 ADLINK Technology Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Amazon Web Services
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Dell Technologies
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 EdgeConnex Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 IBM Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Microsoft Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hewlett Packard Enterprise Development LP (HPE)
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About
14.2 Word Index

LIST OF TABLES

Table 1. Asia Pacific Organoids Market Segmentation
Table 2. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 3. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 4. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 5. China Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 6. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 7. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 8. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 9. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 10. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 11. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 12. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 13. India Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 14. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 15. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 16. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 17. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 18. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Organ Type
Table 19. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 20. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 21. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 22. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) –Organ Type
Table 23. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 24. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
Table 25. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 26. Organic Developments Done by Companies
Table 27. Inorganic Developments Done by Companies
Table 28. Glossary of Terms, Asia Pacific Organoids Market

LIST OF FIGURES

Figure 1. Asia Pacific Organoids Market Segmentation, By Country
Figure 2. Asia Pacific – PEST Analysis
Figure 3. Asia Pacific Organoids Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Organoids Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Asia Pacific Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
Figure 7. Stomach: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Intestine: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Liver: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Pancreas: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Lung: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Brain: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Kidney: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Organoids Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Developmental Biology: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Disease Pathology of Infectious Disease: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Regenerative Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific Organoids Market Revenue Share, by Source 2022 & 2030 (%)
Figure 23. Pluripotent Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Organ-specific Adult Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Organoids Market Revenue Share, by Type 2022 & 2030 (%)
Figure 26. Instruments: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Consumables: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Services: Asia Pacific Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Organoids Market, By Country -Revenue (2022) ($Mn)
Figure 30. Asia Pacific Organoids Market, By Key Countries, 2022 And 2030 (%)
Figure 31. China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 34. Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Pre & Post COVID-19 Impact
Figure 38. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies – Asia Pacific Organoids Market

– Cellesce
– Corning Inc
– InSphero
– Merck KGaA
– STEMCELL Technologies Inc
– Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Organoids Market Forecast to 2030”